Company BrightGene Bio-Medical Technology Co., Ltd.

Company BrightGene Bio-Medical Technology Co., Ltd.

688166

CNE100003PR1

Pharmaceuticals

Equities

688166

CNE100003PR1

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-15 EDT			5-day change	1st Jan Change
34.83 ^CNY	+1.02%		-3.78%	-0.49%

05-07	China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7%	MT
05-07	BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3%	MT

BrightGene Bio-Medical Technology Co Ltd is a China-based company mainly engaged in the research, development and production of generic drugs and original new drugs. The Company's main products include antifungal active pharmaceutical ingredients (APIs), antiviral APIs, immunosuppressive APIs, and other APIs and preparations. The Company's generic drugs mainly include entecavir, caspofungin, micafungin, posaconazole, everolimus and fondaparinux sodium. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 1,155

CNY in Million	2022	Weight	2023	Weight	Delta
Product 86.8 %	878	86.3 %	1,023	86.8 %	+16.63%
Technology 6.4 %	84	8.3 %	76	6.4 %	-10.17%
Equity Share 5.2 %	51	5.1 %	62	5.2 %	+20.46%
Other Business 1.6 %	4	0.4 %	18	1.6 %	+353.84%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	1,017	100.0 %	1,180	100.0 %	+15.94%

Managers	Title	Age	Since
Jian Dong Yuan CEO	Chief Executive Officer	54	01-10-25
Yuan Lai Zou DFI	Director of Finance/CFO	53	10-12-31
Fan Hang BRD	Director/Board Member	38	05-12-31
Yang Qing Huang BRD	Director/Board Member	43	08-12-31
Jing Yan Song IRC	Investor Relations Contact	28	21-09-30
Nan Ding SEC	Corporate Secretary	33	21-04-19
Kai Li PRN	Corporate Officer/Principal	48	06-12-31

Members of the board	Title	Age	Since
Jian Dong Yuan CEO	Chief Executive Officer	54	01-10-25
Kai Li PRN	Corporate Officer/Principal	48	06-12-31
Ying Xian Shen BRD	Director/Board Member	38	17-09-17
Li Zhang BRD	Director/Board Member	42	09-02-28
Lei Su BRD	Director/Board Member	36	17-04-30
Ruyi He BRD	Director/Board Member	63	23-09-17
Xing He CHM	Chairman	41	20-03-31
Jing Fu He BRD	Director/Board Member	39	15-01-31
Fan Hang BRD	Director/Board Member	38	05-12-31
Dong Dong Xu BRD	Director/Board Member	-	23-09-17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	422,466,561	203,822,261 ( 48.25 %)	0	48.25 %

Name	Equities	%	Valuation
Jian Dong Yuan 27.69 %	113,535,123	27.69 %	486 M ¥
Suzhou Borui Xinwen Management Consultancy LP 6.537 %	26,801,844	6.537 %	115 M ¥
Wei Fang Zhong 5.498 %	22,543,669	5.498 %	96 M ¥
SDIC Innovation Investment Management Co. Ltd. 4.540 %	18,612,863	4.540 %	80 M ¥
Hongshan 3.355 %	13,757,411	3.355 %	59 M ¥
GF Fund Management Co., Ltd. 1.898 %	7,783,690	1.898 %	33 M ¥
Huatai Zijin Investment Co., Ltd. 1.747 %	7,162,037	1.747 %	31 M ¥
Suzhou Gaoquan Venture Investment LP 1.410 %	5,780,426	1.410 %	25 M ¥
Hangzhou Mingjia Phase I Equity Investment Partnership LP 1.292 %	5,296,474	1.292 %	23 M ¥
Jiangsu Jingfeng Zhengde Venture Capital Investment Co. Ltd. 1.257 %	5,154,453	1.257 %	22 M ¥

BrightGene Bio-Medical Technology Co., Ltd.

Suzhou Industrial Park Building C25

215123, Suzhou

http://www.bright-gene.com

address BrightGene Bio-Medical Technology Co., Ltd.(688166)

Company calendar

	1st Jan change	Capi.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.	-0.49%	2.04B
ELI LILLY AND COMPANY	+32.36%	694B
NOVO NORDISK A/S	+30.01%	593B
JOHNSON & JOHNSON	-1.60%	371B
MERCK & CO., INC.	+20.07%	331B
ABBVIE INC.	+6.04%	290B
ASTRAZENECA PLC	+14.49%	239B
ROCHE HOLDING AG	-3.31%	209B
NOVARTIS AG	+10.07%	209B
AMGEN INC.	+9.27%	169B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals